Jasper Therapeutics to Present at Upcoming March Investor Conferences
Live webcasts of the presentations will be available on the News & Events – Events page of Jasper's Investor Relations website. An archived replay of each presentation will be available on Jasper's ...
Cellectis Presents ‘Smart CAR T’ Strategy to Enhance Efficacy Against Solid Tumors at ...
Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its ...
Synthetic RIG-I-agonist RNA induces death of hepatocellular carcinoma cells
A new study in the Journal of Interferon & Cytokine Research (JICR) showed that a specific retinoic acid-inducible gene I ...
eLife6 天
SMARCAD1 and TOPBP1 contribute to heterochromatin maintenance at the transition from the 2C ...
The chromatin-bound proteome of embryonic stem cells transitioning to 2C-like cells uncovers chromatin regulators involved in heterochromatin formation.
PharmiWeb6 天
WELIREG® (belzutifan) Receives First European Commission Approval for Two Indications
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the European Commission (EC) has conditionally approved WELIREG® (belzutifan), Merck’s oral ...